Russell E. Scheffer

1.5k total citations
32 papers, 1.1k citations indexed

About

Russell E. Scheffer is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Behavioral Neuroscience. According to data from OpenAlex, Russell E. Scheffer has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 10 papers in Biological Psychiatry and 8 papers in Behavioral Neuroscience. Recurrent topics in Russell E. Scheffer's work include Bipolar Disorder and Treatment (10 papers), Tryptophan and brain disorders (10 papers) and Stress Responses and Cortisol (8 papers). Russell E. Scheffer is often cited by papers focused on Bipolar Disorder and Treatment (10 papers), Tryptophan and brain disorders (10 papers) and Stress Responses and Cortisol (8 papers). Russell E. Scheffer collaborates with scholars based in United States, Denmark and Belgium. Russell E. Scheffer's co-authors include Sahebarao P. Mahadik, E.E. Correnti, Sukdeb Mukherjee, Robert A. Kowatch, A. John Rush, Thomas Carmody, Hemant Kelkar, Jennifer Niskala Apps, David F. Horrobin and K.J. Jenkins and has published in prestigious journals such as American Journal of Psychiatry, PEDIATRICS and Biological Psychiatry.

In The Last Decade

Russell E. Scheffer

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell E. Scheffer United States 16 575 352 185 177 154 32 1.1k
Holly A. Zboyan United States 10 481 0.8× 132 0.4× 469 2.5× 171 1.0× 112 0.7× 12 1.4k
A. Mechri Tunisia 17 612 1.1× 465 1.3× 44 0.2× 176 1.0× 138 0.9× 60 1.5k
Ian Schapkaitz Australia 12 743 1.3× 893 2.5× 34 0.2× 96 0.5× 179 1.2× 14 1.5k
Kristy Lu Australia 5 365 0.6× 526 1.5× 43 0.2× 62 0.4× 159 1.0× 6 1.1k
Murray Anderson‐Hunt Australia 12 644 1.1× 665 1.9× 27 0.1× 92 0.5× 141 0.9× 14 1.3k
Roger B. Varela Brazil 24 522 0.9× 430 1.2× 52 0.3× 29 0.2× 417 2.7× 55 1.4k
Dominik Strzelecki Poland 16 229 0.4× 281 0.8× 39 0.2× 87 0.5× 196 1.3× 102 947
Osman Vırıt Türkiye 12 266 0.5× 288 0.8× 36 0.2× 85 0.5× 94 0.6× 36 677
Bianca Wollenhaupt de Aguiar Brazil 19 198 0.3× 261 0.7× 31 0.2× 131 0.7× 105 0.7× 30 833
Alessandra Frustaci Italy 17 323 0.6× 84 0.2× 47 0.3× 159 0.9× 203 1.3× 22 1.0k

Countries citing papers authored by Russell E. Scheffer

Since Specialization
Citations

This map shows the geographic impact of Russell E. Scheffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell E. Scheffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell E. Scheffer more than expected).

Fields of papers citing papers by Russell E. Scheffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell E. Scheffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell E. Scheffer. The network helps show where Russell E. Scheffer may publish in the future.

Co-authorship network of co-authors of Russell E. Scheffer

This figure shows the co-authorship network connecting the top 25 collaborators of Russell E. Scheffer. A scholar is included among the top collaborators of Russell E. Scheffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell E. Scheffer. Russell E. Scheffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Findling, Robert L., Nora McNamara, Mani N. Pavuluri, et al.. (2018). Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study. Journal of the American Academy of Child & Adolescent Psychiatry. 58(2). 287–296.e4. 22 indexed citations
2.
Findling, Robert L., Adelaide S. Robb, Melissa P. DelBello, et al.. (2017). A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders. Journal of Child and Adolescent Psychopharmacology. 28(1). 47–54. 15 indexed citations
3.
Findling, Robert L., Adelaide S. Robb, Melissa P. DelBello, et al.. (2017). Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients. Journal of Child and Adolescent Psychopharmacology. 27(6). 526–534. 15 indexed citations
4.
Findling, Robert L., Adelaide S. Robb, Melissa P. DelBello, et al.. (2016). 4.62 A SIX-MONTH OPEN-LABEL EXTENSION STUDY OF VORTIOXETINE IN PEDIATRIC PATIENTS. Journal of the American Academy of Child & Adolescent Psychiatry. 55(10). S183–S183. 1 indexed citations
5.
Kowatch, Robert A., et al.. (2015). Placebo-Controlled Trial of Valproic Acid Versus Risperidone in Children 3–7 Years of Age with Bipolar I Disorder. Journal of Child and Adolescent Psychopharmacology. 25(4). 306–313. 17 indexed citations
6.
Scheffer, Russell E., et al.. (2011). Guidelines for Treatment-Resistant Mania in Children with Bipolar Disorder. Journal of Psychiatric Practice. 17(3). 186–193. 6 indexed citations
7.
Scheffer, Russell E., et al.. (2010). Rapid Quetiapine Loading in Youths with Bipolar Disorder. Journal of Child and Adolescent Psychopharmacology. 20(5). 441–445. 6 indexed citations
8.
Scheffer, Russell E.. (2007). Concurrent ADHD and bipolar disorder. Current Psychiatry Reports. 9(5). 415–419. 14 indexed citations
9.
Scheffer, Russell E., et al.. (2007). Concurrent medical conditions with pediatric bipolar disorder. Current Opinion in Psychiatry. 20(4). 398–401. 12 indexed citations
10.
Scheffer, Russell E.. (2006). Psychopharmacology: Clinical Implications of Brain Neurochemistry. Pediatric Clinics of North America. 53(4). 767–775. 5 indexed citations
11.
Scheffer, Russell E. & Jennifer Niskala Apps. (2004). The diagnosis of preschool bipolar disorder presenting with mania: open pharmacological treatment. Journal of Affective Disorders. 82. S25–S34. 32 indexed citations
12.
Scheffer, Russell E., Robert A. Kowatch, Thomas Carmody, & A. John Rush. (2004). Randomized, Placebo-Controlled Trial of Mixed Amphetamine Salts for Symptoms of Comorbid ADHD in Pediatric Bipolar Disorder After Mood Stabilization With Divalproex Sodium. American Journal of Psychiatry. 162(1). 58–64. 165 indexed citations
13.
Scheffer, Russell E.. (2004). Abnormal neurological signs at the onset of psychosis. Schizophrenia Research. 70(1). 19–26. 53 indexed citations
14.
Mahadik, Sahebarao P., et al.. (1998). Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis. Biological Psychiatry. 43(9). 674–679. 143 indexed citations
15.
Mahadik, Sahebarao P., et al.. (1996). Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls. Prostaglandins Leukotrienes and Essential Fatty Acids. 55(1-2). 65–70. 29 indexed citations
16.
Mahadik, Sahebarao P. & Russell E. Scheffer. (1996). Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids. 55(1-2). 45–54. 106 indexed citations
17.
Mahadik, Sahebarao P., Sukdeb Mukherjee, David F. Horrobin, et al.. (1996). Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects. Psychiatry Research. 63(2-3). 133–142. 87 indexed citations
18.
Mahadik, Sahebarao P., et al.. (1995). Mitogenic response to basic fibroblast growth factor (BFGF) in cultured skin fibroblasts from first episode psychosis patients. Schizophrenia Research. 15(1-2). 66–66. 24 indexed citations
19.
Mukherjee, Somnath, et al.. (1994). Membrane fatty acid composition of fibroblasts from schizophrenic patients. Biological Psychiatry. 35(9). 700–701. 7 indexed citations
20.
Mahadik, Sahebarao P., Sukdeb Mukherjee, E.E. Correnti, et al.. (1994). Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis. Schizophrenia Research. 13(3). 239–247. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Holly A. Zboyan Breakdown of academic impact, for papers by A. Mechri Breakdown of academic impact, for papers by Ian Schapkaitz Breakdown of academic impact, for papers by Kristy Lu Breakdown of academic impact, for papers by Murray Anderson‐Hunt Breakdown of academic impact, for papers by Roger B. Varela Breakdown of academic impact, for papers by Dominik Strzelecki Breakdown of academic impact, for papers by Osman Vırıt Breakdown of academic impact, for papers by Bianca Wollenhaupt de Aguiar Breakdown of academic impact, for papers by Alessandra Frustaci
Rankless by CCL
2026